Estradiol (E 2 ) acts through the estrogen receptor (ER) to downregulate many genes, and tamoxifen (Tam) largely reverses this repression but the underlying mechanisms are unclear. Repression of the folate receptor (FR)-a P4 core promoter by ER is enhanced by E 2 and reversed by Tam. This effect was unaffected by inhibition of new protein synthesis and required the E/F and the DNA-binding domains of ER without direct binding of ER to DNA. The repression by E 2 /ER was not specific for either Sp1 or TATA elements but was loosely selective for the initiator and flanking sequence. Insertion of a response element or a relatively strong Sp1 cluster to recruit ER upstream of the core promoters caused a switch to activation by E 2 /ER that was inhibited by Tam. In nuclear extracts, association of ER with a biotinylated core promoter fragment was promoted by E 2 but Tam blocked this effect. Repression/ de-repression of the P4 promoter and endogenous FR-a expression by E 2 /Tam required SMRT and/or NCoR. ER associated with the chromosomal P4 promoter and SMRT and NCoR associated with it in an ER-dependent manner; these associations were favored by E 2 but disrupted by Tam, in the short term, without changes in ER expression. TAFII30 was required for optimal P4 promoter activity and for the repressive association of ER. E2 may thus maintain a low transcriptional status of genes by favoring direct TAFII30-dependent association of ER with the core promoter in a co-repressor complex containing SMRT and/or NCoR; this repression is overridden in target genes containing an upstream element that strongly recruits ER. In addition to suppressing the activation of classical E2 target genes, Tam may upregulate genes by passively dissociating the ER co-repressor complex.
Introduction
Within the large superfamily of nuclear receptors, the estrogen receptor (ER) is among the best characterized as a regulator of gene transcription (Hall et al., 2001; McDonnell, 2005) . Steroid hormone receptors including ER have been grouped as Class 1 nuclear receptors (Mangelsdorf et al., 1995) that typically form homodimers in response to ligand binding and bind to response elements that occur as inverted repeat halfsites in the target gene. ER agonists such as estradiol (E 2 ) induce preferential recruitment of co-activators vs co-repressors by the DNA-bound receptor resulting in transactivation of the target promoter. Selective-estrogen receptor modulators (SERMs) such as tamoxifen (Tam) may bind to ER and act as antagonists of E 2 action by favoring the recruitment of co-repressors (Glass and Rosenfeld, 2000; Smith and O'Malley, 2004; McDonnell, 2005) . Depending upon the cellular and promoter context, SERMs may also act as agonists, behaving like E 2 (Glass and Rosenfeld, 2000; Smith and O'Malley, 2004; McDonnell, 2005) . In contrast, to SERMs, pure ER antagonists, such as ICI 182,780 do not display partial agonist activity. ICI 182,780 acts by decreasing the availability of functional ER by different mechanisms including induction of proteolytic degradation of ER, impairment of ER dimerization and disruption of nuclear localization of ER (Dauvois et al., 1993; Parker, 1993; Pink and Jordan, 1996) . Target genes for activation by E 2 /ER may lack a classical estrogen response element (ERE); in such instances, ER may be tethered to the target promoter by DNA-bound transcription factors such as Sp1 (Safe and Kim, 2004) and AP-1 (DeNardo et al., 2005) .
Recent gene expression profiling studies (Frasor et al., 2003 (Frasor et al., , 2004 Hayashi, 2004; Wang et al., 2004) show that in ER þ cell lines and primary tumors, E 2 inhibits the expression of a large proportion of ER-responsive genes. In MCF-7 breast cancer cells, E 2 inhibited approximately two times as many genes as it activated (Frasor et al., 2003 (Frasor et al., , 2004 . In these cells, Tam completely reversed gene repression by E 2 in 26% of the downregulated genes and partially reversed the repression in 43% of the genes (Frasor et al., 2004) . The remaining 31% of the genes downregulated by E 2 were also inhibited by Tam (Frasor et al., 2004) . There is only a limited amount of mechanistic information on gene repression by E 2 /ER and despite the large number of cases in which Tam reverses the repression the mechanism of Tam action in this context is unclear. In the few examples in which direct gene repression by E 2 /ER has been investigated, it appears that the target genes lack a ERE and that the repressive action is mediated by direct interaction of ER with other transcription factors such as GATA-1 (Blobel et al., 1995) , Sp3/Sp1 (Stoner et al., 2000; Varshochi et al., 2005; Stossi et al., 2006) , AP-1 (Schmitt et al., 1995) , nuclear factor-kB and C/EBPb (Stein and Yang, 1995; Cvoro et al., 2006) . In one instance (Blobel et al., 1995) , the repressive effect of E 2 /ER is thought to be due to interference with the interaction of a transcription factor (GATA-1) and in two instances (Varshochi et al., 2005; Stossi et al., 2006) the repression involved recruitment of histone deacetylase. Further, among these examples, GATA-1-mediated repression is the only case in which Tam has been shown to reverse the repression by E 2 (Blobel et al., 1995) .
Understanding the different mechanisms by which E 2 / ER and the prototypical SERM, Tam, regulate model genes is necessary to identify SERMs that are dissociated from regulatory characteristics that are undesirable for their use in cancer chemoprevention/therapy. We have previously reported (Kelley et al., 2003) that the TATA-less and Sp1-dependent folate receptor (FR)-a P4 promoter and endogenous FR-a expression are repressed in the short term by ER type a (referred to here as ER) in a manner that is enhanced further by E 2 and that this repression is relieved by Tam and ICI 182, 780 . ERb repressed the promoter only modestly compared to ERa but did not interfere with the ERa effect. We reported a limited initial promoter analysis involving an essential G/C-rich (Sp1-binding) element in the promoter and also observed that when this element was mixed with a nuclear extract, ER very weakly associated with it. In light of the known ability of ER and Sp1 to associate physically with each other, the data were interpreted to suggest that the repressive action of ER occurred through its tethering to the P4 promoter through Sp1 (Kelley et al., 2003) . A closer investigation of the mechanism of repression of the FR-a P4 promoter by ER and its de-repression by Tam reported here, discounts a role for Sp1. This study points instead to the initiator and flanking sequence within the core promoter (that may contain either G/C-rich or TATA box elements) as the principal determinant of the direct and repressive action of a co-repressor complex comprising ER and SMRT and/or NCoR on the basal promoter activity. Evidence is presented to support a model in which de-repression by Tam occurs by its ability to disrupt such a co-repressor complex. The results also show that when either a classical ERE or a relatively strong cluster of Sp1 elements that strongly recruits ER is present, it will override the repressive association of ER with the core promoter. Further, TAFII30 is required for optimal activity of the P4 core promoter and also mediates its repressive association with ER. This model is consistent with the emerging concept (Smale and Kadonaga, 2003) of core promoter diversity that influences the formation and composition of the transcription pre-initiation complex. The ligand dependence of ER and co-repressor associations with the promoter as well as the ligand effects on the target gene expression are considerably more pronounced in the chromosomal context. The findings contribute to a further mechanistic understanding of the global effects of E 2 /Tam on gene expression.
Results
The action of ER/E 2 /Tam on the P4 promoter does not require intermediate protein synthesis
We have previously reported that the P4 promoter of the FR-a gene is repressed by ER and that E 2 promotes this repression whereas Tam reverses it (Kelley et al., 2003) . The protein synthesis inhibitor, cycloheximide (CHX), was used to test whether the regulation of the P4 promoter and FR-a gene expression by ER ligands could be indirect, mediated by a protein product(s) of one or more upstream target genes of ER. HeLa cells were transfected with an expression plasmid for ER and a P4 promoter-luciferase reporter plasmid; 48 h later the effect of a 12 h treatment with E 2 , alone or in combination with Tam, on the mRNA level of the luciferase reporter was tested either in the presence or in the absence of CHX (Figure 1 ). The ability of CHX to inhibit protein synthesis was confirmed by the lack of luciferase activity in cells transfected for 12 h with the P4 promoter-luciferase plasmid in the presence of CHX (data not shown). CHX was unable to affect repression of the luciferase mRNA expression by E 2 or its Figure 1 Effect of inhibiting de novo protein synthesis on the action of ER on the FR-a P4 promoter. Hela cells (10 6 ) were transfected with 400 ng of FR-a -P4 promoter-luciferase (P4-luc) and 50 ng ER-expression plasmid for 48 h. Then the cells were pretreated with either CHX (10 mM) or vehicle for 2 h followed by the introduction of E 2 (10 nM) or Tam (1 mM) as indicated. Fourteen hours later, the cells were harvested for measurement of luciferase reporter mRNA by real-time RT-PCR. The ability of CHX to inhibit completely protein synthesis was confirmed by the lack of luciferase activity resulting from a 12 h treatment with CHX of cells transfected with P4-luc during this period (data not shown). P-values for the differences noted in the text were o0.0001. CHX, cycloheximide.
Estrogen-induced and TAFII30-mediated gene repression H Hao et al de-repression by Tam (Figure 1 ), indicating that the regulation of the P4 promoter through ER did not require de novo protein synthesis.
Identification of the minimal determinant of negative ER regulation within the P4 promoter The TATA-less P4 promoter of the FR-a gene includes three non-canonical Sp1-binding elements (Figure 2a ) that cumulatively contribute to the promoter activity; the most proximal Sp1 element, however, is absolutely required for promoter activity (Saikawa et al., 1995) . When, in the minimal P4 promoter, the entire Sp1-binding region was replaced by a TATA box (Figure 2a) , the promoter was active (Figure 2b ). Like the P4 promoter, this promoter construct was repressed by E 2 /ER and de-repressed by Tam (Figure 2b) , suggesting that the ER regulation of the P4 promoter did not require aN Sp1-binding element. ) were transfected with 400 ng of P4-luc, P4 min-luc or TATA-P4InrF-luc and co-transfected with 50 ng of either ER-expression plasmid or the vector control. Cells were treated with vehicle, E 2 (10 nM) or E 2 (10 nM) plus Tam (1 mM) as indicated for the duration of the transfection (48 h) after which they were harvested to measure luciferase activity. (c) HeLa (10 6 ) cells were transfected with 400 ng of P4-luc, or the chimeric promoter luciferase constructs: P4/RSV InrF , P4/TK InrF or P4/ SV40 InrF . The cells were co-transfected with 50 ng of either ER-expression plasmid or the vector control. Cells were treated with vehicle, E 2 (10 nM) or E 2 (10 nM) plus Tam (1 mM) as indicated for the duration of the transfection (48 h) after which they were harvested to measure luciferase activity. (d) HeLa cells containing stably integrated P4-luc, P4/RSV InrF -luc or ERE-TK-luc were transfected with ER by nucleofection and treated with vehicle, E 2 (10 nM) or E 2 (10 nM) plus Tam (1 mM) as indicated for 48 h. The cells were then harvested to measure luciferase activity. (e) The ER-positive T47D-B cells were infected with lentiviruses expressing luciferase driven by either the FR-a P4 promoter or the ERE-TK promoter and treated with vehicle, E 2 (10 nM) or E 2 (10 nM) plus Tam (1 mM) as indicated for 48 h. RNA was isolated from the cells and the mRNA level of luciferase was measured by real-time RT-PCR. (The lentivirus expresses both luciferase and GFP. Because GFP interferes with the luciferase activity assay, the mRNA levels of luciferase were measured instead.) (f) HeLa cells (10 6 ) were transfected with 400 ng of ERE-P4-luc, ERE-TATA-P4InrF-luc or SV40(GC) 6 -P4InrF-luc. ER-expression plasmid (50 ng) or the plasmid vector (50 ng) was co-transfected with each promoter luciferase construct, as indicated. Cells were treated with vehicle, E 2 (10 nM) or E 2 (10 nM) plus Tam (1 mM) as indicated for the duration of the transfection (48 h) after which they were harvested to measure luciferase activity. All values represent the mean7s.d. from three or more independent experiments. P-values for the differences noted in the text were o0.0001. ER, estrogen receptor; ERE, estrogen response element; FR, folate receptor.
Estrogen-induced and TAFII30-mediated gene repression H Hao et al Next, the portion of the core promoter comprising the initiator and flanking (InrF) sequence, in the P4 promoter, was substituted with those of the SV40, thymidine kinase (TK) or RSV promoters (Figure 2a) . The InrF sequence is defined here as the region between the TATA box or Sp1 element most proximal to the initiator and extending downstream of the initiator to the beginning of the luciferase reporter sequence (Figure 2a) . Thus the InrF sequence is devoid of TATA or Sp1 elements. All of the chimeric promoters showed basal promoter activity. However, whereas the P4/ SV40 InrF and the P4/TK InrF chimeras responded to ER regulation similar to the P4 promoter (Figure 2c) , the P4/RSV InrF chimera did not (Figure 2c) , suggesting that the nature of the InrF sequence and not upstream Sp1 or TATA elements accounts for core promoter selectivity in the repressive action of E 2 /ER and derepression by Tam.
Repression of the core promoter by ER in the chromatin context and by endogenous ER The ability of the core promoter to be repressed by E 2 and de-repressed by Tam in the chromatin context was tested by generating recombinant HeLa cells in which the following promoter-reporter constructs were stably integrated: P4 promoter-luciferase, P4/RSV InrF -luciferase or ERE-TK-luciferase, which is an ERE-dependent promoter. As seen in Figure 2d , in the chromatin context, the core P4 promoter was repressed by E 2 and this repression was completely reversed by Tam. In contrast, E 2 increased the activity of the ERE-TK promoter in a manner that was inhibited by Tam. The P4/RSV InrF promoter chimera was not repressed by E 2 . This pattern of regulation by E 2 and Tam is consistent with the promoter analysis described above using transient transfections.
To test whether endogenous ER could regulate the core P4 promoter similar to ectopically introduced ER, the ER-positive T47D-B cells were infected with lentivirus for chromosomal integration of P4 promoter-luc or ERE-TK-luc ( Figure 2e ). In these cells also, E 2 repressed the P4 promoter and Tam reversed this repression; in contrast the ERE-TK promoter was activated by E 2 and this activation was blocked by Tam ( Figure 2e ). Thus, the action of transfected ER in HeLa cells reflects that of endogenous ER in T47D-B cells.
Upstream elements strongly recruiting ER override core promoter repression by E 2 /ER It has been established that ER may be recruited to promoters either by direct binding to a classical ERE or by association with DNA-bound Sp1. When a classical ERE was placed directly upstream of the minimal P4 promoter or the promoter in which the Sp1 element was replaced by a TATA box (Figure 2a ), E 2 /ER enhanced the promoter activity and Tam inhibited this activation ( Figure 2f ). Similarly, when the relatively weak Sp1 element in the basal P4 promoter was replaced by a cluster of six canonical Sp1 elements derived from the SV40 promoter (Figure 2a ), the promoter activity was increased by E 2 /ER in a manner that was inhibited by Tam ( Figure 2f ). The results indicate that recruitment of ER to upstream elements prevents core promoter repression by ER.
ER domains required for its action on the P4 promoter
Since the P4 promoter lacks a classical ERE, it was of interest to identify the ER-protein domains that were required for regulating the P4 promoter. Deletion mutants of ER lacking either the E/F domain or the A/B domain as well as an ER chimera (ER/GalDBD), in which the DNA-binding domain (DBD) of ER was replaced by the Gal4-DNA-binding domain (GalDBD) were tested ( Figure 3) . The results showed that the E/F domain but not the A/B domain was required for the negative regulation of the P4 promoter and for derepression by Tam (Figure 3 ). Further, ER/GalDBD did not repress the P4 promoter ( Figure 3 ). On the basis of known functions of ER domains, the results indicate that the ligand-independent transactivation function (within the A/B domain) of ER is not required for regulating the P4 promoter. The DBD of ER is apparently required for repression of the P4 promoter.
Differential ligand effects on the association of ER with ERE vs core promoter DNA fragments Synthetic biotinylated DNA fragments corresponding to a classical ERE and core promoter fragments comprising the P4 promoter InrF either with or without an upstream TATA box ( Figure 4a ) were compared in terms of their ability to associate with ER by a in vitro 10 6 ) were transfected with 400 ng of FR-a -P4 promoter-luciferase (P4-luc) and 50 ng of expression plasmid for a mutant ER (ER-ABCD) in which the EF domain was deleted, a mutant ER (ER-CDEF) in which the AB domain was deleted, or a chimeric ER (ER/GalDBD) in which the DBD of ER was replaced by the Gal4 DBD. The transfected cells were treated with vehicle, E 2 (10 nM) alone or E 2 (10 nM) plus Tam (1 mM) for 48 h and then harvested for luciferase assays. Values represent the mean7s.d. from three or more independent experiments. P-values for the differences noted in the text were o0.0001. DBD, DNAbinding domain; ER, estrogen receptor; Tam, tamoxifen.
DNA 'pull down' assay ( Figure 4b ). (Synthesis of a biotinylated P4 promoter fragment was not feasible due to length constraints.) The biotinylated DNA fragments were incubated with nuclear lysates from HeLa cells transiently expressing ER in the presence of vehicle, E 2 or Tam followed by 'pull down' of the proteins associated with the biotinylated DNA using immobilized streptavidin and western blot analysis of the proteins. As expected, the ERE fragment specifically associated with ER and this association was increased by both E 2 and Tam (Figure 4b ). The core promoter fragment also specifically associated with ER in a manner that was enhanced by E 2 but in contrast to the ERE fragment, the association of ER was decreased by Tam (Figure 4b ). The InrF fragment alone (without the TATA box) did not associate with ER significantly above background levels (that is in the absence of a DNA probe) (Figure 4b ). These results indicate that ER is physically recruited to the core promoter in a manner that is promoted by E 2 but inhibited by Tam. The results also indicate that to recruit ER, the entire core promoter that is required to form a pre-initiation complex, is needed.
ER associates with the P4 promoter in situ in a ligand-dependent manner The preceding results suggested a direct action of ER on the FR-a P4 promoter by its recruitment to the core promoter. Therefore, the ability of ER to associate directly with the P4 promoter in the endogenous FR-a gene was tested by the ChIP assay, in which the relative degrees of association of ER with the promoter were quantified using real-time PCR (Figure 5a ). As seen in Figure 5a , ER associated with the P4 promoter in the chromatin context; this association was increased by E 2 but decreased by Tam. Under these treatment conditions, the level of ER, detected by western blot, was not significantly altered (Figure 5b ).
SMRT and NCoR associate with the P4 promoter in situ in an ER and ligand-dependent manner As noted previously (Kelley et al., 2003) , overexpression of the ER co-repressor SMRT substantially enhanced the repressive effect of E 2 /ER on the P4 promoter but overexpression of a number of co-activators, including SRC-1, TIF-2, RAC-3, CBP and pCAF did not have an appreciable effect. On the other hand, an effect of the various co-regulators on de-repression by Tam was either absent or marginal (Kelley et al., 2003) . Since SMRT appeared to play a role in the negative regulation of the P4 promoter by E 2 /ER, the possibility that similar to ER, the co-repressors SMRT and NCoR may associate with the P4 promoter in the endogenous FRa gene was tested by the quantitative ChIP assay described above. Both SMRT (Figure 5c ) and NCoR ( Figure 5d ) associated with the P4 promoter but this association required the presence of ER. Further, similar to ER, the association of SMRT or NCoR was increased by E 2 and decreased by Tam (Figures 5c and  d) . (In Figure 5c , SMRT was introduced ectopically because the available antibody to SMRT could not efficiently immunoprecipitate the relatively low amount of endogenous SMRT and because we had previously shown that ectopic SMRT increases P4 promoter repression by ER.)
Functional role of SMRT and NCoR in mediating the effect of ER on the P4 promoter and on FR-a expression To confirm further a functional role for SMRT and NCoR in mediating ER regulation of the P4 promoter, the effect of decreasing the level of endogenous SMRT or NCoR on ER regulation of both the P4 promoter activity and expression of the endogenous FR-a gene was examined. In HeLa cells, siRNA designed to knockdown SMRT or NCoR substantially decreased SMRT or NCoR expression at both the mRNA (Figure 6a ) and protein ( Figure 6b ) levels, in contrast to a scrambled siRNA control. Knockdown of either SMRT or NCoR substantially decreased the extent of ligand-dependent repression/de-repression of the P4 promoter and this effect was more pronounced when both SMRT and NCoR were simultaneously knocked down (Figure 6c ). These observations are consistent with a role for SMRT and NCoR in mediating the repression by ER.
T47D-B cells express both FR-a and ER and were chosen to examine the effect of knocking down SMRT and NCoR on the regulation of the endogenous FR-a through the endogenous ER. In T47D-B cells the mRNA for SMRT or NCoR was decreased by the siRNAs for SMRT and NCoR, respectively ( Figure 7a) ; this was reflected by a decrease in the protein levels for or E 2 (10 nM) plus Tam (1 mM) for 1 h and then harvested to prepare nuclear lysates. The nuclear lysates were incubated in the presence of either vehicle or the appropriate ligands with biotinylated synthetic versions of the P4 promoter InrF, TATAInrF or a canonical ERE. The DNA probes and associated proteins were pulled down using streptavidin sepharose beads, resolved by SDS-PAGE, transferred to nitrocellulose and probed with antibody to ER. Lane 10 represents a negative control in which the nuclear lysate was treated with E 2 (10 nM) but no DNA probe was present. ERE, estrogen response element.
SMRT and NCoR (Figure 7b ). The endogenous FR-a in T47D-B cells was substantially decreased by E 2 in a manner that was reversed by Tam (Figure 7c ). The combined knockdown of SMRT and NCoR abrogated this decrease in FR-a caused by E 2 and the addition of Tam did not significantly alter FR-a expression (Figure 7c ). This result demonstrates that SMRT and NCoR are required for repression/de-repression of the endogenous FR-a gene by ER ligands.
Role of TAFII30 in mediating ER recruitment at the P4 promoter and its repression TAFII30 was tested as a candidate protein of the preinitiation complex involved in the repressive association of ER with the P4 core promoter, since this protein is known to have the ability to directly associate with ER (Jacq et al., 1994) . siRNA targeting TAFII30 substantially decreased the mRNA for TAFII30 in HeLa cells (Figure 8a ). The decrease in TAFII30 mRNA was reflected in a substantial decrease in the protein level (Figure 8b ). Knocking down TAFII30 caused a decrease in the basal P4 promoter activity suggesting a functional association of TAFII30 with the promoter (Figure 8c ). In contrast, the knockdown did not appreciably affect the activity of the ERE-TK promoter (Figure 8c) , suggesting selectivity in the interaction of TAFII30 with the P4 promoter. Knockdown of TAFII30 substantially decreased P4 core promoter repression by E 2 /ER ( Figure 8d) ; in contrast, knocking down TAFII30 did not appreciably affect the activation of the ERE-TK promoter by E 2 /ER (Figure 8e ).
Knocking down TAFII30 also abolished the E 2 -induced association of ER with the P4 promoter in the chromosome context in situ as observed by the ChIP assay (Figure 8f ). It should be noted that in the ChIP assay in Figure 8f , the brief treatment with E 2 followed complete knockdown of TAFII30 whereas in the promoter activity assay in Figure 8d the treatment with E 2 was for 48 h and concomitant with the progressive decrease in TAFII30 due to the transfected siRNA; therefore, the effect of the TAFII30 knockdown on the promoter repression by ER may be expected to be apparently incomplete. The results clearly indicate that the repressive association of ER with the core promoter characterized in the previous experiments is dependent upon the presence of TAFII30.
Discussion
The minimal FR-a P4 promoter is negatively regulated by E 2 /ER in a manner that is reversed by Tam. This regulation is mediated by both ectopically introduced and endogenous ER. The degree of repression/ de-repression of the minimal P4 promoter is similar to that of longer promoter constructs. The E 2 -dependent Figure 5 ChIP assay of the in situ association of ER, SMRT or NcoR with the FR-a gene. HeLa cells were transfected with either the ER-expression plasmid or the vector (negative control) as indicated. Forty-eight hours after transfection, cells were treated with vehicle, E 2 (10 nM) alone or E 2 (10 nM) plus Tam (1 mM) for 1 h and then subjected to ChIP as described under Materials and methods. The relative amount of target genomic DNA fragment pulled down by antibody to ER (a), SMRT (c) or NcoR (d) was quantified by real-time PCR. The values represent the mean of triplicates. Each assay was repeated at least four times, and concordant results were obtained. In (b), the ER-expression level in transfected HeLa cells was analysed by western blot. P-values for the differences noted in the text were o0.0001. ER, estrogen receptor; Tam, tamoxifen.
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repression by ER also occurs in the chromosomal context as evident from an examination of stably integrated promoter constructs, the association of ER and co-repressors with the chromosomal P4 promoter and the expression of endogenous FR-a. A classical response element for ER cannot be identified within the P4 promoter. In addition to regulating genes by binding to classical hormone response elements, nuclear receptors have been shown to associate with DNA and repress genes by binding to elements termed 'negative hormone response elements (nHREs)' (Aranda and Pascual, 2001; Moehren et al., 2004) . Such elements have been characterized for glucocorticoid and thyroid hormone receptors, and typically occur near the transcription initiation sites of the target genes but may also occur in the 3 0 -untranslated region. Further, in most cases, the hormone receptors bound to nHREs activate transcription in the absence of ligand and repress it in the presence of hormone. Despite the requirement for the DBD of ER in repressing the P4 promoter, electrophoretic mobility shift assays using 40-mer synthetic oligonucleotide duplexes with 20 bp overlaps failed to reveal direct binding of ER to any segment within the entire InrF region of the P4 promoter (data not shown). Further, 'DNA pull down' assays failed to show direct binding of ER to the InrF fragment of the P4 promoter in the absence of Sp1 or TATA elements, indicating the absence of a nHRE for ER in the P4 Figure 6 The effect of knocking down SMRT or NcoR on the action of ER on the FR-a P4 promoter. HeLa cells were transfected with scrambled siRNA (control), or siRNA for SMRT and/ or NcoR. Forty-eight hours after transfection, the cells were co-transfected with P4 promoter-luc and ER-expression plasmid. The cells were treated with vehicle, E 2 (1 nM) or E 2 (1 nM) plus Tam (1 mM) for the duration of the second transfection (48 h). At the end of the second transfection, the cells were harvested for measurement of mRNA levels of SMRT and NCoR by RT-PCR and realtime PCR (a) or the protein expression levels of SMRT or NCoR by western blot (b). At this time, the luciferase activity in the cells was measured to determine P4 promoter activity (c). P-values for the differences noted in the text were o0.001. siRNA, small interfering RNA.
promoter. Nevertheless, several lines of evidence indicate a direct action of ER on the promoter: they include (i) the inability to prevent or alter this regulation by blocking de novo protein synthesis using CHX, (ii) specific association of ER with a core promoter fragment in nuclear extracts in vitro in the presence of (10 6 ) were co-nucleofected with scrambled siRNA (control) or siRNA to TAFII30 and P4 promoter-luciferase plasmid (200 ng) together with either ER-expression plasmid (25 ng) or a plasmid vector control (25 ng). Twenty-four hours after nucleofection the cells were treated with E 2 (1 nM) for a further 48 h and then harvested to measure luciferase activity in the lysates. (e) HeLa cells (10 6 ) were co-nucleofected with scrambled siRNA (control) or siRNA to TAFII30 and ERE-TK promoter-luciferase plasmid (200 ng) together with either ER-expression plasmid (25 ng) or a plasmid vector control (25 ng). Twenty-four hours after nucleofection the cells were treated with E 2 (1 nM) for a further 48 h and then harvested to measure luciferase activity in the lysates. (f) HeLa cells (10 6 ) were co-nucleofected with either the ER-expression plasmid (50 ng) or the plasmid vector (negative control) together with either siRNA to TAFII30 or a scrambled siRNA (control). Forty-eight hours later cells were treated with vehicle or E 2 (10 nM) for 2 h and then subjected to ChIP as described under Materials and methods. The relative amount of target genomic DNA fragment pulled down by antibody to ER and was quantified by real-time PCR. The values represent the mean of triplicates7s.d. P-values for the differences noted in the text wereo0.0001. ER, estrogen receptor; ERE, estrogen response element; siRNA, small interfering RNA.
NCoR with the P4 promoter in situ measured by the ChIP assay. The parallel functional effects of ER ligands on the P4 promoter activity and FR-a expression vs the association of ER, SMRT or NCoR with the P4 promoter provide evidence of the functional nature of the physical associations of ER, SMRT and NCoR with the promoter. This is further supported by the relationship between SMRT or NCoR expression levels and (i) repression/de-repression of the P4 promoter activity by E 2 /Tam and (ii) the decrease in endogenous FR-a upon treatment of ER-positive cells with E 2 and its reversal by Tam. The FR-a gene is thus a non-classical but direct target for negative regulation by E 2 /ER and de-repression by Tam. A minimal P4 promoter construct consisting of only a single Sp1 element that is essential for basal promoter activity and the downstream sequence (À36 to þ 33) (InrF) encompassing the transcription start site retained the ER responsiveness of the FR-a promoter. This sequence constitutes only the essential 'core promoter' (Smale and Kadonaga, 2003) for a TATA-less gene. Replacing the Sp1 element in this construct with a TATA box retained basal promoter activity and converted it into a TATA-dependent core promoter. The TATA-dependent core promoter construct also retained the ER regulation of the P4 promoter, excluding a role for the Sp1 element in mediating the ER effect. Evidence that the promoter selectivity of repression by E 2 /ER is determined by the nature of the InrF was obtained from the observation that the InrF of the P4 promoter could be replaced by that of the SV40 promoter or the TK promoter but not the RSV promoter without a loss of this repression. However, in an in vitro assay in the presence of nuclear proteins, only an intact core promoter but not the InrF alone could bind ER in a ligand-dependent manner. This observation suggests that at least a part of the transcription pre-initiation complex needs to be formed to recruit physically and functionally ER to the core promoter.
Our studies show that the mode of recruitment of ER to a promoter clearly determines its functional consequence. Thus, the introduction of either a classical ERE or a cluster of strong canonical G/C-rich (Sp1-binding) elements upstream of the core promoter overrides the repressive association of E 2 /ER with a core promoter and results in its activation. In the absence of an upstream element that can recruit ER, the receptor had the ability to repress the basal activity of promoter constructs containing the InrF regions of different promoters (FR-a, TK, SV40) suggesting that ER may be generally repressive to a broad range of genes, by acting at the level of the core promoter. The repressive interaction of ER with the core promoter requires the DNA-binding and E/F domains; whereas the E/F domain is known to contain the ligand-binding pocket and co-regulator binding motifs, the role of the DBD in this context is unclear.
The lack of an appreciable effect of overexpressing known co-activators of ER (SRC-1, TIF-2, RAC-3, CBP and pCAF) on the repression of the FR-a P4
promoter by E 2 /ER or its induction (de-repression) by Tam in our previous report (Kelley et al., 2003) indicates that the co-activators are not involved in the regulation of the FR-a gene through ER. In contrast, the effect of overexpression of SMRT, showed that the ER corepressor potentiates repression of the P4 promoter by E 2 /ER but does not determine the promoter activity in the presence of Tam (Kelley et al., 2003) . A role for ER co-repressors in the repression of the P4 promoter by E 2 /ER is confirmed by the effects of knocking down SMRT or NCoR on ER regulation of both the P4 promoter and the endogenous FR-a gene expression. Our studies also show that SMRT and NCoR associate physically with the P4 promoter region of the endogenous FR-a gene in a manner that is (i) ER dependent, (ii) promoted by E 2 and (iii) inhibited by Tam. These observations, taken together with the functional data, imply that repression of the P4 promoter is mediated by the association of a complex containing ER and SMRT and/or NCoR with the core promoter and that derepression by Tam is a passive process involving dissociation of ER, SMRT and NCoR.
Nuclear receptors may regulate transcription by interacting with general transcription factors in the pre-initiation complex (Baniahmad et al., 1993; Fondell et al., 1993 Fondell et al., , 1996 Jacq et al., 1994; Sadovsky et al., 1995; Schulman et al., 1995; Tong et al., 1995; Masuyama et al., 1997; Mengus et al., 1997) . Such interactions may be selective for the type of nuclear receptors or for the promoter. The co-repressors, SMRT and NcoR, have also been shown to associate functionally with TAFs and TFIIB (Muscat et al., 1998; Wong and Privalsky, 1998) . Although some degree of promoter selectivity is implied in these interactions of nuclear receptors and coregulators based on the variable complement of TAFs, the actual recruitment of the receptors (and in turn the co-regulators) to the target promoter is believed to be mediated by cis-elements or DNA-bound proteins distinct from the core promoter. Thus, the classical targets for each nuclear receptor comprise a limited class of genes. The results in this study demonstrate that a core promoter is, in and of itself, adequate to recruit ER, SMRT and NCoR that together repress it in a hormone-dependent manner and that the selectivity of this interaction is loosely related to features of the initiator and flanking sequence that are yet to be identified. Further, whereas the basal transcriptional activities of genes may be kept in check by E 2 /ER in this manner, gene repression by ER at the core promoter level is simply overridden in target genes that strongly recruit ER to other sites. Our studies demonstrate that TAFII30, which is present in a subset of TFIID complexes and is a component of the pre-initiation complex known to associate directly with ER (Jacq et al., 1994) , mediates repression in the conformational context of direct ER recruitment by the P4 core promoter. The observed requirement of the E/F domain of ER for its repressive action is also consistent with the previously noted ER-domain specificity for binding to TAFII30. Such a mechanism may in part provide a basis to explain the recent findings of a relatively large number of genes that are repressed by estrogen in a manner that is reversible by Tam (Frasor et al., 2003 (Frasor et al., , 2004 .
Consensus elements commonly found in core promoters include (i) the initiator encompassing the þ 1 position, (ii) an upstream TATA box, which in TATAless promoters is commonly replaced by G/C-rich elements that bind Sp family proteins and (iii) the downstream promoter element (DPE) located at þ 28 to þ 32. Recent studies have revealed that these elements may occur in variable combinations giving rise to diversity among core promoters (Smale and Kadonaga, 2003) . Additional sequence elements that are less characterized are also suspected to contribute to the variability in the organization of the core promoter (Smale and Kadonaga, 2003) . It has been proposed that such a structural diversity among core promoters may permit variability in the patterns of gene regulation by transcription factors acting at the level of assembly of the pre-initiation complex (Smale, 2001; Butler and Kadonaga, 2002; Smale and Kadonaga, 2003) . This view of the core promoter offers a conceptual framework for the direct and repressive association of ER and SMRT or NCoR with the core promoters of a set of genes whose expression is increased by Tam by passive de-repression.
Materials and methods

DNA constructs and expression plasmids
The constructs were generated either by PCR or by using synthetic oligonucleotides. In the construct SV40(GC) 6 -P4InrF, the G/C-rich region of the FR-a P4 promoter (À147 to À18) was replaced by the G/C-rich region (À113 to À43) of the SV40 promoter. In the P4/SV40 InrF construct, the FR-a P4 InrF (À28 to þ 33) was replaced with the SV40 InrF (À48 to þ 65). The 5 0 deletion constructs of the FR-a P4 promoter (À272 to þ 33) and P4min (À49 to þ 33) were constructed by PCR. In the construct TATA-P4InrF, the G/C-rich sequence (À49 to À35) within the FR-a P4 promoter-luciferase construct was replaced by a TATA-box element (5 0 -AATAAT TAA-3 0 ) using PCR. The ERE-P4min and ERE-TATA-P4 InrF constructs were constructed by inserting double-stranded synthetic oligonucleotides corresponding to the sequence (5 0 -G GTACCTCAGGTCACAGTGACCTGATCAGGTCACAGTG ACCTGATCAGGTCACAGTGACCTGAGAGCTC-3 0 ) into P4 min or TATA-P4 InrF. In the construct P4/rous sarcoma virus (RSV InrF ), the InrF sequence (À35 to þ 33) within the FR-a P4 promoter-luciferase construct was replaced by a RSV InrF sequence (À21 to þ 22) using PCR, In P4/TK InrF , the FR InrF (À35 to þ 33) was replaced by the TK InrF (À19 to þ 33). The ER-ABCD and ER-CDEF constructs were generated by PCR.
Construction and packaging of recombinant lentiviruses and infection of cells
The FR-a P4 promoter (À175 to þ 33 ) was amplified from the FR-a promoter luciferase construct in pGL3 Basic vector with the upstream primer 5 0 -ACAATGGGCCCGTGACCACCT GGAGAAGG-3 0 and downstream primer 5 0 -ACTGCTCGA GAGAAAGAGCTGTGGTCAGTGGCACC-3 0 . The ERE-TK promoter was amplified from an ERE-TK luciferase construct (plasmid XETL) with the upstream primer 5 0 -ATATGGGCC CAATTAACCCTCACTAAAGGG-3 0 and downstream primer 5 0 -ATATCTCGAGATCTGCGGCACGCTGTTGACG-3 0 . Both PCR products were cloned into the parental lentiviral construct pLL3.7 in front of a luciferase and green fluorescent protein (GFP) gene. The lentiviruses were packaged by transfecting 293 FT cells using LipofectAMINE 2000. Viruses were harvested at 48 and 72 h and concentrated by ultracentrifugation at 25000 r.p.m. for 90 min at 41C. T47D-B cells were infected with lentivirus at 30% confluence in the presence of polybrene (8 mg/ml) and then treated with vehicle, E 2 or E 2 plus Tam. RNA was isolated 48 h after treatment and the luciferase mRNA levels were measured by real-time reverse transcription (RT)-PCR.
Cell culture and transfection T47D-B cells were provided by Dr Katherine Horwitz. 293 FT cells were provided by Dr Kam Yeung. T47D-B cells were cultured in phenol red-free minimum essential medium (MEM) supplemented with fetal bovine serum (FBS) (5%), penicillin (100 U/ml), streptomycin (100 mg/ml), L-glutamine (2 mM), 1 Â MEM non-essential amino acid and G418 (200 mg/ml). HeLa (American Type Culture Collection) cells were cultured in phenol red-free MEM supplemented with FBS (10%), penicillin (100 U/ml), streptomycin (100 mg/ml) and L-glutamine (2 mM). 293 FT cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with heatinactivated FBS (10%), penicillin (100 U/ml), streptomycin (100 mg/ml), L-glutamine (2 mM), 1 Â MEM non-essential amino acid and G418 (0.5 mg/ml). Three days before transfection and after transfection, HeLa cells were grown in phenol red-free media supplemented with charcoal-stripped FBS (5%, v/v), L-glutamine (2 mM), insulin (2 mg/ml), and transferrin (40 mg/ml). E 2 or Tam was used where indicated at the concentrations specified. HeLa cells were transfected with DNA constructs in six-well plates (Corning, New York, NY, USA) using FuGENE 6 (Roche Diagnostics, Indianapolis, IN, USA), according to the manufacturer's protocol. The b-galactosidase expression plasmid, pSV-b-gal (Promega, Madison, WI, USA) was co-transfected to monitor uniformity of transfection. b-Galactosidase activity was measured by the colorimetric assay system from Promega.
Stable transfection
HeLa cells were cotransfected in 100-mm plates at 60% confluence with 9 mg each of the appropriate promoterluciferase construct and 3 mg pcDNA1/Neo plasmid (Invitrogen, Carlsbad, CA, USA) using Fugene (Roche) according to the vendor's protocol. Twenty-four hours after transfection, the cells were transferred into DMEM containing G418 (0.5 mg/ml; Gibco-BRL, Grand Island, NY, USA). The cells were selected for G418 resistance for 3 weeks, pooled, and seeded in six-well plates for the nucleotransfection of ER using the Amaxa Nucleofection System (Amaxa Biosystems, Gaithersburg, MD, USA) according to the vendor's instruction. The cells were treated with vehicle, E 2 or E 2 plus Tam for 48 h, and then the cell lysates were assayed for luciferase activity.
DNA pull-down assay HeLa cells were transfected with ER-expression plasmid or plasmid vector (negative control). Forty-eight hours after transfection, cells were treated with vehicle, E 2 (1 nM) or E 2 (1 nM) plus Tam (1 mM) for 1 h, washed two times with phosphate-buffered saline (PBS) and harvested in PBS. Cell pellets were lysed with lysis buffer (400 mM NaCl, 10 mM Tris, pH 8.0, 1 mM ethylenediaminetetraacetic acid (EDTA), 1 mM ethylene glycol bis(aˆ-aminoethylether)-N,N,N 0 ,N 0 ,-tetraacetic acid (EGTA), 0.1% Triton X-100; 1 mM phenylmethylsulfonyl fluoride, and 5 mg/ml each of aprotinin, leupeptin and pepstatin A), supplemented with vehicle, E 2 (10 nM) or E 2 (100 nM) plus Tam (1 mM). The lysates were centrifuged at 16 000 g for 10 min and the resultant supernatants were diluted 1:4 with dilution buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 0.5 mM EGTA, 10% glycerol, 0.25% nonidet P-40) in the presence of ligand as indicated. Then 300 mg of lysate was incubated with 1 mg of the appropriate biotinylated DNA probe and 10 mg poly(dI-dC) at 41C on a rotary shaker for 1 h, and then incubated with 30 ml of 50% (v/v) streptavidinsepharose beads overnight. The samples were centrifuged at 600 g for 5 min, and the pellets were washed four times with washing buffer (10 mM Tris-HCl, pH 8.0; 1 mM EDTA; 0.5 mM EGTA; 100 mM NaCl; 10% glycerol; 0.25% nonidet P-40) in the presence of ligand for 5 min with rotation. The proteins were released by boiling in 100 ml sodium dodecyl sulfate (SDS) loading buffer (62.5 mM Tris-HCl, pH 6.8; 10% glycerol; 2% SDS; 5% 2-mercaptoethanol; and 0.00125% bromophenol blue) and resolved by SDS-polyacrylamide gel electrophoresis (PAGE) and western blots were probed for ER. The 5 0 biotin-labeled probes were: TATA-P4 InrF (5 0 -biotin-CTTACGCGTAATAATTAATGGAGCCCTGCACACAAC TTAAGGCCCC ACCTCCGCATTCCTTGGTGCCACTG ACCACAGCTCTTTCTTCAGGGA-3 0 ), P4InrF (5 0 -biotin-TGGAGCCCTGCACACAACTTAAGGCCCCACCTCCGC ATTCCTTGGTGCCACTGACCACAGCTCTTTCTTCAGG GA-3 0 ) and ERE (5 0 -biotin-GTCCAAAG TCAGGTCACA GTGACCTGATCAAAGTT-3 0 ).
Gene silencing with siRNAs
The small interfering RNA (siRNA) for TAFII30 was nucleofected using the Amaxa Nucleofection System (Amaxa Biosystems) according to the vendor's instruction. The siRNA sequence for TAFII30 is CCGGAGATGCAGTGACTGGT TACTCGAGTAGTAACCAGTCACTGCATCTTTTTT (from Sigma MISSION shRNA). HeLa Cells were plated at 40% confluency and transfected with siRNA (75 mM) for SMRT or NCoR (Yoon et al., 2003 ) using LipofectAMINE 2000 . Forty-eight hours after transfection of siRNA, 400 ng of FR-a P4-luciferase construct and 50 ng of ERexpression plasmid were transfected using Fugene 6 (Roche) and incubated in media in the presence of the appropriate ligand as indicated for 48 h, and then harvested for luciferase assay. T47D-B cells were incubated for 5 days in the presence of the appropriate ligand after transfection of siRNA, and then FR-a expression was visualized by western blot. Hela cells were also nucleofected with human TAFII30 siRNA and 25 or 50 ng of ER-expression plasmid and plated at 4 Â 10 6 cells per in 10-cm plates in phenol red-free MEM, supplemented with FBS (10%), penicillin (100 U/ml), streptomycin (100 mg/ml) and L-glutamine (2 mM). Twenty-four hours after nucleofection, cells were grown in phenol red-free media supplemented with charcoal-stripped FBS (5%, v/v), L-glutamine (2 mM), insulin (2 mg/ml), and transferrin (40 mg/ml) and treated with vehicle or 100 nM E2 for 48 h. Cells were harvested for luciferase activity assay 72 h post-nucleofection.
RNA isolation, RT-PCR and real-time PCR Total RNA was prepared using the RNeasy Mini kit (Qiagen, Maryland, MD, USA) and reverse-transcribed with random primers by using a reverse transcriptase kit (Applied Biosystems, Foster City, CA, USA) according to the manufacturers' protocol. The reverse transcription product was measured by quantitative real-time PCR using the Real-time PCR master mix (Applied Biosystems) in the 7500 Real-Time PCR System (Applied Biosystems). The primers and TaqMan probe for SMRT (Kershah et al., 2004) , NCoR (Kershah et al., 2004) or luciferase was purchased from Integrated DNA Technologies Inc. (Coralville, IA, USA). The primers and the TaqMan probe for the human TAFII30 and control glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene were purchased from Applied Biosystems. All samples were measured in triplicate and normalized to GAPDH values.
Chromatin immunoprecipitation assay
HeLa cells were transfected with ER-expression plasmid or plasmid vector. Forty-eight hours after transfection, cells were treated with vehicle, E 2 (10 nM) or E 2 (10 nM) plus Tam (1 mM) for 60 min, and then subjected to the crosslinking reaction using formaldehyde (1%). Chromatin immunoprecipitation (ChIP) assays were performed as described previously (Hao et al., 2003) with the following modifications. ChIP signals were measured by real-time PCR analysis of chromatinimmunoprecipitated products. The optimal target sequence chosen to amplify the P4 promoter region was À171 to À80. The following primers and TaqMan probe were used for the real-time PCR assay: TaqMan probe, 5 0 -FAM-TGGTGTC TAATCCTACCTTTCATT-TAMRA-3 0 ; forward primer, 5 0 -CCCCCATCTCCCTCAGTTTT-3 0 ; reverse primer, 5 0 -CCAC CTGGAGAAGGCAATGA-3
0 . Each sample was tested in triplicate. For the non-target exon sequence 4000 bp downstream of the P4 promoter in the FR-a gene (negative control), the following probes were used: TaqMan probe, FAM-CCT TGCCCAACCTTTCCATTTCTACTTCCCC-TAMRA-3 0 ; forward primer, 5 0 -AGGTGCGCAGTGGGAGCT-3 0 ; reverse primer, 5 0 -CATTGCACAGAACAGTGGGTG-3 0 .
